KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet needs.
|Data provided by Nasdaq. Minimum 15 minutes delayed. |
View Attributions and Sources
November 08, 2017KalVista Pharmaceuticals to Present at Stifel Healthcare Conference
October 10, 2017KalVista Pharmaceuticals Announces Collaboration with Merck
September 14, 2017KalVista Pharmaceuticals Reports Fiscal First Quarter ResultsMore News
There are currently no events scheduled.More Events